Milk Clotting Enzyme, Aspergillus Oryzae Recombinant

Milk Clotting Enzyme from Aspergillus Oryzae Recombinant is a protease enzyme produced through recombinant DNA technology. The enzyme is derived from the filamentous fungus Aspergillus oryzae, which is widely recognized as safe for food applications and has a long history of use in fermented food production, particularly in Asia. The recombinant version is created by introducing genes that code for milk-clotting protease activity into laboratory strains of A. oryzae, allowing manufacturers to produce the enzyme in controlled, scalable quantities.

This enzyme is primarily used in cheese manufacturing as a coagulant. During traditional cheesemaking, rennet—historically sourced from calf stomach lining—is added to milk to cause coagulation, separating the liquid whey from solid curds. Milk clotting enzymes from A. oryzae serve as a biotechnological alternative to animal-derived rennet. This application is particularly valuable for vegetarian and vegan cheese production, as it eliminates the need for animal products while maintaining consistent enzymatic activity. The enzyme facilitates the formation of the milk curd structure, which is essential for producing cheeses of various types and styles.

The safety profile of this enzyme appears favorable based on available evidence. Aspergillus oryzae is a microorganism with an established history of safe use in food production, particularly in Japanese koji fermentation for sake, miso, and other traditional foods. The FDA has not received any reported adverse events associated with this specific enzyme formulation, and no recalls have been documented in the FDA database. The enzyme itself is a protease that breaks down proteins—a mechanism similar to natural digestive processes—and would be denatured during cooking and cheese aging.

Recombinant enzymes used in food applications are generally considered safe because they are identical in structure and function to their naturally occurring counterparts. The production organism and the genetic modifications used do not themselves appear in the final food product; only the purified enzyme is present in cheese. Standard toxicology assessments for food enzymes typically include studies on acute toxicity and the enzyme's susceptibility to degradation in simulated digestive conditions.

As of current records, this specific enzyme has not received FDA GRAS (Generally Recognized as Safe) status. However, this does not necessarily indicate a safety concern; rather, it may reflect that a formal GRAS petition has not been submitted to the FDA, or that the enzyme is marketed under alternative regulatory pathways. In the European Union, similar milk-clotting enzymes from Aspergillus oryzae have been evaluated and approved under food enzyme regulations. The absence of regulatory approval should not be conflated with evidence of unsafety.

Manufacturers seeking to use this enzyme in the United States must ensure compliance with applicable FDA regulations, including provisions under the Food Additives Amendment if the enzyme is considered a food additive in its intended use.

Limited published research specifically on this recombinant strain exists in open literature, which is typical for proprietary enzyme formulations. However, scientific literature on Aspergillus oryzae-derived proteases demonstrates their effectiveness and safety in food applications. Studies on recombinant milk-clotting enzymes from various fungal sources confirm they perform comparably to animal rennet in cheese production, with equivalent coagulation profiles and cheese quality outcomes. The enzyme's protease specificity and pH optimum have been characterized in technical literature supporting its food applications.